368 related articles for article (PubMed ID: 20930286)
1. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
2. mRNA levels of BACE1 and its interacting proteins, RTN3 and PPIL2, correlate in human post mortem brain tissue.
Beyer N; Coulson DT; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
Neuroscience; 2014 Aug; 274():44-52. PubMed ID: 24853053
[TBL] [Abstract][Full Text] [Related]
3. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains.
Harada H; Tamaoka A; Ishii K; Shoji S; Kametaka S; Kametani F; Saito Y; Murayama S
Neurosci Res; 2006 Jan; 54(1):24-9. PubMed ID: 16290302
[TBL] [Abstract][Full Text] [Related]
4. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
Beyer N; Coulson DT; Heggarty S; Ravid R; Hellemans J; Irvine GB; Johnston JA
J Alzheimers Dis; 2012; 29(4):863-73. PubMed ID: 22349685
[TBL] [Abstract][Full Text] [Related]
5. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
6. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AbetaPP mRNA isoforms containing the Kunitz protease inhibitor.
Barrachina M; Dalfó E; Puig B; Vidal N; Freixes M; Castaño E; Ferrer I
Neurochem Int; 2005 Feb; 46(3):253-60. PubMed ID: 15670642
[TBL] [Abstract][Full Text] [Related]
8. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
Rossner S; Sastre M; Bourne K; Lichtenthaler SF
Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
[TBL] [Abstract][Full Text] [Related]
10. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease.
Borghi R; Patriarca S; Traverso N; Piccini A; Storace D; Garuti A; Gabriella Cirmena ; Patrizio Odetti ; Massimo Tabaton
Neurobiol Aging; 2007 Jul; 28(7):1009-14. PubMed ID: 16769154
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
12. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
[TBL] [Abstract][Full Text] [Related]
13. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).
Kuzuya A; Uemura K; Kitagawa N; Aoyagi N; Kihara T; Ninomiya H; Ishiura S; Takahashi R; Shimohama S
J Neurosci Res; 2007 Jan; 85(1):153-65. PubMed ID: 17075903
[TBL] [Abstract][Full Text] [Related]
14. BACE1 in Alzheimer's disease.
Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.
Imamura K; Hishikawa N; Ono K; Suzuki H; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
Acta Neuropathol; 2005 Feb; 109(2):141-50. PubMed ID: 15619128
[TBL] [Abstract][Full Text] [Related]
16. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.
Stockley JH; Ravid R; O'Neill C
FEBS Lett; 2006 Dec; 580(28-29):6550-60. PubMed ID: 17113083
[TBL] [Abstract][Full Text] [Related]
17. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H; Shen Y
Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor Yin Yang 1 is an activator of BACE1 expression.
Nowak K; Lange-Dohna C; Zeitschel U; Günther A; Lüscher B; Robitzki A; Perez-Polo R; Rossner S
J Neurochem; 2006 Mar; 96(6):1696-707. PubMed ID: 16539685
[TBL] [Abstract][Full Text] [Related]
19. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]